BDBM50458629 CHEMBL4210670

SMILES: CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(cc3)-c3ccc(=O)[nH]c3)cc2C(F)(F)F)CC1

InChI Key: InChIKey=LBELDIIRDVZLHQ-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50458629   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Proto-oncogene tyrosine-protein kinase receptor Ret (Homo sapiens (Human))	BDBM50458629 (CHEMBL4210670) Show SMILES CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(cc3)-c3ccc(=O)[nH]c3)cc2C(F)(F)F)CC1 Show InChI InChI=1S/C26H28F3N5O2/c1-2-33-11-13-34(14-12-33)17-20-5-9-22(15-23(20)26(27,28)29)32-25(36)31-21-7-3-18(4-8-21)19-6-10-24(35)30-16-19/h3-10,15-16H,2,11-14,17H2,1H3,(H,30,35)(H2,31,32,36)	PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.20	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibition of human RET using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by HT...				ACS Med Chem Lett 9: 623-628 (2018) Article DOI: 10.1021/acsmedchemlett.8b00035 BindingDB Entry DOI: 10.7270/Q2TB19GW
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM50458629 (CHEMBL4210670) Show SMILES CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(cc3)-c3ccc(=O)[nH]c3)cc2C(F)(F)F)CC1 Show InChI InChI=1S/C26H28F3N5O2/c1-2-33-11-13-34(14-12-33)17-20-5-9-22(15-23(20)26(27,28)29)32-25(36)31-21-7-3-18(4-8-21)19-6-10-24(35)30-16-19/h3-10,15-16H,2,11-14,17H2,1H3,(H,30,35)(H2,31,32,36)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	95	n/a	n/a	n/a	n/a	n/a	n/a
GlaxoSmithKline Curated by ChEMBL					Assay Description Inhibition of human KDR using cisbio TK biotin-peptide as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by...				ACS Med Chem Lett 9: 623-628 (2018) Article DOI: 10.1021/acsmedchemlett.8b00035 BindingDB Entry DOI: 10.7270/Q2TB19GW
					More data for this Ligand-Target Pair